Drugs / Globulina antilinfocitaria
last change Aug 2011 re-read 2 minutes ago

Globulina antilinfocitaria

Developed for
acute myeloid leukemia · chronic myeloid leukemia · lymphoproliferative syndrome · myelodysplastic syndrome · myelofibrosis · precursor lymphoblastic lymphoma/leukemia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT00354120 Comparator Mar 2005 → Aug 2011 acute myeloid leukemia, chronic myeloid leukemia, lymphoproliferative syndrome, myelodysplastic syndrome +2 Italian Group for Bone Marrow Transplantation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Globulina antilinfocitaria ClinicalTrials.gov intervention name — accepted as the source's own label NCT00354120